President Trump wants to bring pharmaceutical manufacturing back to the United States. Experts warn that tariffs could result ...

Global pharmaceutical manufacturing industry market will reach $25.77 billion by 2032, growing by 9.3% annually over 2022-2032. The growth is driven by the increased drug approvals, increasing ...

According to a factsheet published by the Trump administration, pharmaceuticals are exempted from the tariffs – for now.

Drugmakers are lobbying Trump to phase in tariffs on imported pharmaceutical products in hopes of reducing the sting from the ...

Europe pharmaceutical manufacturing industry market was valued at $2.84 billion in 2022 and will grow by 8.6% annually over 2022-2032. The growth is driven by the increased drug approvals, increasing ...

Analysts said tariffs would send prescription drug prices higher. Generic drugs and ingredients that are largely made ...

The U.S. pharmaceutical industry is bracing for a possible wave of tariffs on foreign-made drugs, even as they received a short-term exemption this week under President Donald Trump’s sweeping new ...

Indian pharmaceutical stocks tumbled 4.4% on Friday, erasing gains from the previous session, after Trump threatened steep ...

Large-cap pharmaceutical stocks like these may now be positioned to outperform as the impact of tariffs begins to take hold.

The fear of a trade war over pharmaceuticals between the EU and the US has been avoided for now, but the European Commission ...

US President Donald Trump has again singled out Ireland's pharmaceutical industry as a target for tariffs. Trump was speaking ...